- Raised $27.4M Public Offering, Nov 2015
- Raised $9.8M Undisclosed Round, Oct 2017
- Raised $590k Undisclosed Round, Nov 2024
About
The Trendlines Group is an Israel-based life sciences innovation commercialization company that invents, discovers, invests in, partners, and incubates innovation-based medical and agricultural technologies. It operates through four business units: two Israeli government-franchised incubators (Trendlines Medical and Trendlines Agtech), a Singapore incubator (Trendlines Medical Singapore), and an in-house innovation center (Trendlines Labs). The company's mission is to improve the human condition by creating and developing technology-based companies in the medical and agricultural fields, with a view toward successful exits. Trendlines is publicly traded on the Singapore Stock Exchange (SGX: 42T) and offers American Depositary Receipts in the U.S. (OTCQX: TRNLY).
Portfolio · 1
Q&A
- What was Trendlines Group's most recent investment?
- Trendlines Group's most recent investment was in Dasyo Technologies in November 2021.
- Can you name a notable company in Trendlines Group's portfolio?
- A notable company in Trendlines Group's portfolio is Dasyo Technologies, which develops a skin-tightening device.
- What is the range of investment amounts for Trendlines Group?
- According to startupim data, Trendlines Group's investment range is between $650K and $1.1M.
- When was Trendlines Group's first recorded investment?
- Trendlines Group's first recorded investment was in VivoText in January 2008, participating in a $650K Seed round.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | The Trendlines Group Ltd. |
|---|---|
| Founded | 2007-5 |
Radar intelligence
Patents
| EPO | 8 |
|---|